Emeritus Professor Sue Tett
Emeritus Professor

Sue Tett

Email: 

Background

Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)

Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.

Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.

Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.

Availability

Emeritus Professor Sue Tett is:
Available for supervision
Media expert

Fields of research

Health Sciences Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • Clinical pharmacokinetics and pharmacodynamics

    Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).

  • Quality use of Medicines

    Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use

Search Professor Sue Tett’s works on UQ eSpace

309 works between 1985 and 2020
All (309) Journal Article (163) Book Chapter (3) Conference Publication (135) Book (5) Other Outputs (3)

21 - 40 of 309 works

2017

Journal Article

Ezetimibe: use, costs, and adverse events in Australia

Hollingworth, Samantha A., Ostino, Remo, David, Michael C., Martin, Jennifer H. and Tett, Susan E. (2017). Ezetimibe: use, costs, and adverse events in Australia. Cardiovascular Therapeutics, 35 (1), 40-46. doi: 10.1111/1755-5922.12236

Ezetimibe: use, costs, and adverse events in Australia

2017

Journal Article

New-onset diabetes after statin exposure in elderly women: the Australian longitudinal study on women’s health

Jones, Mark, Tett, Susan, Peeters, Geeske M. E. E., Mishra, Gita D. and Dobson, Annette (2017). New-onset diabetes after statin exposure in elderly women: the Australian longitudinal study on women’s health. Drugs and Aging, 34 (3), 1-7. doi: 10.1007/s40266-017-0435-0

New-onset diabetes after statin exposure in elderly women: the Australian longitudinal study on women’s health

2016

Conference Publication

Evolving Australian, and Northern European, Utilisation Patterns for Immunosuppressants After Transplantation

Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2016). Evolving Australian, and Northern European, Utilisation Patterns for Immunosuppressants After Transplantation. HOBOKEN: WILEY-BLACKWELL.

Evolving Australian, and Northern European, Utilisation Patterns for Immunosuppressants After Transplantation

2016

Journal Article

Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease

Peeters, Geeske, Tett, Susan E., Hollingworth, Samantha A., Gnjidic, Danijela, Hilmer, Sarah N., Dobson, Annette J. and Hubbard, Ruth E. (2016). Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease. Journals of Gerontology - Series A: Biological Sciences and Medical Sciences, 72 (2), 259-265. doi: 10.1093/gerona/glw111

Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease

2016

Journal Article

Population pharmacokinetic modelling and bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet?

Brooks, Emily, Tett, Susan E., Isbel, Nicole M. and Staatz, Christine E. (2016). Population pharmacokinetic modelling and bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 55 (11), 1295-1335. doi: 10.1007/s40262-016-0396-1

Population pharmacokinetic modelling and bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet?

2016

Journal Article

Associations between statin use and physical function in older adults from the Netherlands and Australia: longitudinal aging study Amsterdam and Australian longitudinal study on women’s health

van Boheemen, Laurette, Tett, Susan E., Sohl, Evelien, Hugtenburg, Jacqueline G., van Schoor, Natasja M. and Peeters, G. M. E. E. (2016). Associations between statin use and physical function in older adults from the Netherlands and Australia: longitudinal aging study Amsterdam and Australian longitudinal study on women’s health. Drugs and Aging, 33 (6), 437-445. doi: 10.1007/s40266-016-0370-5

Associations between statin use and physical function in older adults from the Netherlands and Australia: longitudinal aging study Amsterdam and Australian longitudinal study on women’s health

2016

Journal Article

Multinational evaluation of mycophenolic acid, tacrolimus, cyclosporin, sirolimus, and everolimus utilization

Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2016). Multinational evaluation of mycophenolic acid, tacrolimus, cyclosporin, sirolimus, and everolimus utilization. Annals of Transplantation, 21, 1-11. doi: 10.12659/AOT.895664

Multinational evaluation of mycophenolic acid, tacrolimus, cyclosporin, sirolimus, and everolimus utilization

2015

Journal Article

The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study

van der Hoorn, Mariëlle M. C., Tett, Susan E., de Vries, Oscar J., Dobson, Annette J. and Peeters, G. M. E. E. G. (Geeske) (2015). The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study. Bone, 81, 675-682. doi: 10.1016/j.bone.2015.08.024

The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study

2015

Journal Article

Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications

Barozzi, Nadia, Peeters, GMEE Geeske and Tett, Susan E. (2015). Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications. BMC Health Services Research, 15 (498) 498, 498. doi: 10.1186/s12913-015-1165-9

Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications

2015

Journal Article

Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis

Abd Rahman, Azrin N., Tett, Susan E., Abdul Gafor, Halim A., Mcwhinney, Brett C. and Staatz, Christine E. (2015). Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis. British Journal of Clinical Pharmacology, 80 (5), 1064-1075. doi: 10.1111/bcp.12678

Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis

2015

Journal Article

Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients

Staatz, Christine E. and Tett, Susan E. (2015). Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients. Clinical Pharmacokinetics, 54 (10), 993-1025. doi: 10.1007/s40262-015-0282-2

Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients

2015

Conference Publication

Pharmacokinetic modelling of enterohepatic circulation of mycophenolic acid in Malaysian lupus nephritis patients

Abd Rahman, Nurul Azrin, Tett, Suszn E., Abdul Gafor, Abdul Halim, McWhinney, Brett D. and Staatz, Christine E. (2015). Pharmacokinetic modelling of enterohepatic circulation of mycophenolic acid in Malaysian lupus nephritis patients. Population Approach Group in Australia and New Zealand conference, Melbourne, Australia, January 16, 2015.

Pharmacokinetic modelling of enterohepatic circulation of mycophenolic acid in Malaysian lupus nephritis patients

2015

Journal Article

Is statin use associated with new joint-related symptoms, physical function and quality of life? The Australian Longitudinal Study on Women’s Health

Peeters, Geeske, Tett, Susan E., Conaghan, Philip G., Mishra, Gita D. and Dobson, Annette J. (2015). Is statin use associated with new joint-related symptoms, physical function and quality of life? The Australian Longitudinal Study on Women’s Health. Arthritis Care and Research, 67 (1), 13-20. doi: 10.1002/acr.22389

Is statin use associated with new joint-related symptoms, physical function and quality of life? The Australian Longitudinal Study on Women’s Health

2015

Conference Publication

Proton Pump Inhibitors-Should More Care Be Taken with Prescribing for Older Women?

Tett, Susan E., van der Hoorn, Marielle M. C., Dobson, Annette J. and Peeters, Geeske G. M. E. E. (2015). Proton Pump Inhibitors-Should More Care Be Taken with Prescribing for Older Women?. International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Boston, MA, United States, 22-26 August 2015. HOBOKEN: WILEY-BLACKWELL. doi: 10.1002/pds.3838

Proton Pump Inhibitors-Should More Care Be Taken with Prescribing for Older Women?

2015

Conference Publication

Evolving utilisation patterns in Australia of immunosuppressants after transplantation including comparison to Northern European countries

Gardiner, K. M., Tett, S. E. and Staatz, C. E. (2015). Evolving utilisation patterns in Australia of immunosuppressants after transplantation including comparison to Northern European countries. APSA-ASCEPT Joint Scientific Meeting 2015, Hobart, Australia, 29 November-2 December 2015.

Evolving utilisation patterns in Australia of immunosuppressants after transplantation including comparison to Northern European countries

2014

Journal Article

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy

Peeters, Geeske, Tett, Susan E., Duncan, Emma L., Mishra, Gita D. and Dobson, Annette J. (2014). Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy. Pharmacoepidemiology and Drug Safety, Early View (12), 1303-1311. doi: 10.1002/pds.3703

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy

2014

Journal Article

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

Staatz, Christine E. and Tett, Susan E. (2014). Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Archives of Toxicology, 88 (7), 1351-1389. doi: 10.1007/s00204-014-1247-1

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

2014

Journal Article

How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2014). How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?. Clinical Pharmacokinetics, 53 (3), 227-245-227-245. doi: 10.1007/s40262-013-0124-z

How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

2014

Conference Publication

Use of Ezetimibe in Australia

Hollingworth, Samantha A., Ostini, Remo, Michael, David, Martin, Jennifer and Susan, Tett (2014). Use of Ezetimibe in Australia. 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Taipei, Taiwan, 24–27 October 2014. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/pds.3701

Use of Ezetimibe in Australia

2014

Conference Publication

Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe

Staatz, C. E., Gardiner, K. M. and Tett, S. E. (2014). Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe. Joint meeting of ASCEPT and Molecular Pharmacology of G protein-coupled receptors (MGPPCR), Melbourne, Australia, 7-11th December 2014.

Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe

Past funding

  • 2014 - 2015
    Fun 'n fitness: Evaluation of the Churches of Christ in Queensland Falls Prevention Exercise Program for its Aged Care Residents
    Churches of Christ in Queensland
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2013 - 2014
    Utilisation review of Ezetimibe
    Department of Health and Ageing
    Open grant
  • 2009 - 2010
    Safety and quality of medication use - can this be improved through understanding/building on health professional networks
    The JO and JR Wicking Trust
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Uni of Southampton Evaluation of Nurse & Pharmacist Prescribing
    University of Southampton
    Open grant
  • 2009 - 2013
    Commercial influences on community pharmacist recommendations and their impact on patient's quality use of medicines
    Pharmacists Board of Queensland
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    Pilot study to include community pharmacies in distribution of prescription medicine starter packs
    Pharmaceutical Society of Australia
    Open grant
  • 2007
    Prescription medicine samples and therapy initiation: developing a best practice system with community pharmacists in Australia
    Pharmaceutical Society of Australia
    Open grant
  • 2006 - 2008
    Understanding and Improving Prescribing Practice
    National Prescribing Service Limited
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2011
    Multicentre Drug Use Evaluation and other quality use of medicines activities in hospitals
    National Prescribing Service Limited
    Open grant
  • 2004 - 2006
    National Strategy for Quality Use of Medicines
    Department of Health and Ageing
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2003 - 2005
    Multi-centre drug use evaluation in hospitals
    National Prescribing Service Limited
    Open grant
  • 2003 - 2005
    Rural Community Pharmacists Integrating Care for People With Complex Health Needs
    Pharmacy Guild of Australia
    Open grant
  • 2003 - 2005
    Rural community pharmacists integrating care for people with complex health needs.
    Department of Health and Ageing
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Community pharmacists providing clinical services for dispensing doctors and depot pharmacies in rural Queensland - telepharmacy
    Pharmacy Guild of Australia
    Open grant
  • 2002 - 2005
    Pharmacokinetic and pharmacodynamic studies of the newer immunosuppressants
    NHMRC Project Grant
    Open grant
  • 2000 - 2001
    Appropriate prescriptyion of ipratropium bromide, including route of administration, both in hospital and on discharge
    National Prescribing Service Limited
    Open grant
  • 2000 - 2001
    Quality Use of Medicines Research
    Queensland Health
    Open grant
  • 1999 - 2001
    Pharmacists assisting GP's in the co-ordination of care for complex needs patients in rural and remote areas
    Pharmacy Guild of Australia
    Open grant
  • 1999 - 2001
    Population pharmacokinetics, pharmacodynamics and dosage prediction for tacrolimus
    NHMRC Project Grant
    Open grant
  • 1999
    The use of therapeutic flags to highlight potentially inappropriate prescribing in the elderley
    National Prescribing Service Limited
    Open grant
  • 1997 - 2000
    Quality use of medication, pharmacokinetics, pharmacodynamics and optimal dose prediction
    NHMRC Project Grant
    Open grant
  • 1996 - 1998
    Fluconazole renal elimination processes in HIV infection and iatrogenic immunosuppression
    NHMRC Project Grant - HIV/AIDS (CARG)
    Open grant
  • 1995 - 1996
    Rational therapy of rheumatic disease with hydroxychloroquine
    Sterling Pharmaceuticals Pty Limited
    Open grant

Availability

Emeritus Professor Sue Tett is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Towards optimal dosing of new immunosuppressant drugs in solid organ transplants

    Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered

  • International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage

    International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems

  • Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and

    Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc

  • Drug usage evaluation across different jurisdictions

    Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences

  • Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug

Supervision history

Completed supervision

Enquiries

Contact Emeritus Professor Sue Tett directly for media enquiries about:

  • Clinical pharmacokinetics
  • Clinical pharmacy
  • Medicine - quality use of
  • Pharmacokinetics
  • Pharmacy - clinical

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au